Benzinga
'Penalty Is Warranted' - DoT Notifies Southwest Airlines Over Holiday Flight Fiasco
Healthcare Property Firms Healthpeak Properties And Physicians Realty Trust To Merge In $21B Deal
Google Could Turn Your Wireless Earbuds Into Heart Rate Monitors With A Simple Software Update
Toyota's September Sales Grow Aided By Strong Demand; 1H Sales Jump As Semiconductor Shortage Eases
Rivian To Start Billing For Its Charging Network
GM, Ford Supplier Autoliv Slashes France Headcount By 20%
- Automotive safety systems supplier Autoliv Inc (NYSE:ALV) plans to reduce its headcount in France as part of the previously announced initiatives to reduce its global headcount and optimize its footprint.
- In June, Autoliv announced its intention to reduce up to 2,000 indirect employees.
Risk of Eye Infection - FDA Issues Strong Warning on Eye Drops from Major Retailers
- On Friday, the FDA issued a warning to consumers, cautioning them against the use of 26 over-the-counter eye drops from various brands.
- The FDA's advisory stems from concerns that these eye drops may lead to eye infections and, in some instances, potential vision loss.
- The eye drops are primarily designed to alleviate symptoms of dry eyes and relieve eye irritation.
Wall Street Journal
Battle for Disney's Future - Nelson Peltz Gains Strong Backing from Perlmutter
Bloomberg
TC Energy Explores Asset Sales Worth $10B, Debt Reduction on the Horizon
Reuters
Amazon Leverages Generative AI for Holiday Ad Boost, Targeting 160M Prime Subscribers
Blackstone Forays Into Indian Healthcare Sector Through Stake In Care Hospitals
Earnings
McDonald's Price Hike Serves Up Tasty Margins in Q3 Earnings Feast!
Panasonic Posts Strong H1 Profits, But Lowers FY24 Guidance On Deteriorating Market Conditions
Western Digital To Split Business, Shifts Focus After Varied Segmental Performance in Q1
Transportation & Logistics Company XPO's Q3 Earnings Beat Consensus
- XPO Inc (NYSE: XPO) reported third-quarter FY23 revenue growth of 1.7% year-over-year to $1.98 billion, beating the consensus of $1.93 billion.
- Adjusted EPS was $0.88, down from $0.95 in 3Q22, beating the consensus of $0.63.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
